CATALYST PHARMACEUTICALS, INC. (CPRX)
Pharmaceutical Preparations
Latest Price
$31.49
TTM P/E
18.20
Normalized P/E
29.56
Div Yield
--
Book Value
8.28
P/B Ratio
3.80
Valuation metrics
adjust assumptions →EPS: $1.68
Book value / share: $7.79
Formula: √(22.5 × EPS × BVPS)
Graham Number
$17.16
46% downside
Norm. op. income: $87M (median of 7yr)
Tax rate: 24%
Discount rate: 10%
Growth assumption: zero (EPV is a no-growth value)
Earnings Power Value
$11.15
65% downside
Base FCF: $143M (median of recent 5yr)
Growth: 25%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$92.88
+195% upside
EPS: $1.68
Target P/E: 30×
Formula: EPS × P/E
P/E Fair Value
$50.40
+60% upside
Institutional Ownership
82.8% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 18.77M | $464.0M | 15.37% | +147.7K | 2026-03-31 |
| STATE STREET CORP | 6.86M | $169.0M | 5.62% | -44.6K | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 5.12M | $126.0M | 4.19% | -- | 2026-03-31 |
| AMERICAN CENTURY COMPANIES INC | 4.14M | $102.0M | 3.39% | +1.11M | 2026-03-31 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 3.94M | $97.0M | 3.23% | -967.6K | 2026-03-31 |
| DIMENSIONAL FUND ADVISORS LP | 3.43M | $84.0M | 2.81% | +433.3K | 2026-03-31 |
| BANK OF AMERICA CORP /DE/ | 3.04M | $75.0M | 2.49% | +836.7K | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.97M | $73.0M | 2.43% | +72.1K | 2026-03-31 |
| MORGAN STANLEY | 2.69M | $66.0M | 2.20% | -246.1K | 2026-03-31 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2.48M | $61.0M | 2.03% | -- | 2026-03-31 |